Drug recall · July 17, 2024
Lidocaine HCL Injection recall
Why: Subpotent Drug: reduced efficacy for epinephrine
Class II: could cause temporary or reversible health problems; serious harm is remote.
The recall
- Product
Lidocaine HCL Injection, USP 2% 200mg/10mL (20mg/mL) and EPINEPHRINE HCl 1:200,000, 10 ml Single Dose Vial, Rx only, Compounded drug by Medivant Healthcare, 158 S Kyrene Rd, Chandler, AZ 85226, NDC 81483-0038-0, UPC 3 81483 00380 2
- Lots / codes
Lot Number: 2311003, Expiration Date: 11/13/2024
- Quantity
- 12,525 10 mL vials
- Company
- Tailstorm Health Inc, Chandler, AZ
- Distribution
- Nationwide in the USA
- Initiated
- July 3, 2024 · Voluntary: Firm initiated
- Classified
- July 10, 2024
- Reported
- July 17, 2024
- How notified
- Letter
The drug: prices, other makers, shortages
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.
Watch Epinephrine
One email when the price moves, a recall or shortage is posted, or the label changes. Plus the monthly biggest-movers report. Unsubscribe in one click.